Frazier Management LLC Chinook Therapeutics, Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$12.02 - $16.69 $28.5 Million - $39.6 Million
-2,371,918 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$10.69 - $16.83 $7.48 Million - $11.8 Million
700,000 Added 41.87%
2,371,918 $38.7 Million
Q3 2021

Nov 12, 2021
BUY
$11.5 - $14.86 $6.58 Million - $8.5 Million
571,918 Added 51.99%
1,671,918 $21.3 Million
Q2 2021

Aug 11, 2021
BUY
$13.6 - $18.98 $15 Million - $20.9 Million
1,100,000 New
1,100,000 $15.5 Million

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email